[伊卡林改善了雄性小鼠的布苏尔和环胺诱导的生殖功能损伤]
Yao Wu1, Shan-Shan Shi2, Hai-Yan Liu1
1School of Ecology, Lishui College, Lishui, Zhejiang 323000, China.
Zhonghua nan ke xue = National journal of andrology
|August 10, 2025
概括
伊卡林通过减少丸细胞中的氧化应激和亡来保护男性生殖功能. 这种天然化合物增强了精子的生产,并改善了生殖损伤的小鼠的丸结构.
科学领域:
- 生殖生物学 生殖生物学
- 药理学 药理学是指药理学的学科.
- 毒理学 毒理学 毒理学
背景情况:
- 男性生殖功能障碍是一个越来越令人担忧的问题.
- 氧化应激和亡在丸损伤中起着关键作用.
- 自然化合物正在探索其治疗潜力.
研究的目的:
- 评估伊卡林在男性小鼠减轻生殖功能损伤 (RFD) 的有效性.
- 为了研究伊卡林保护作用的潜在机制.
主要方法:
- 在体外莱迪格细胞测定和体内研究中使用busulfan和cyclophosphamide诱导的RFD小鼠模型.
- 评估生殖器官系数,精子数,丸组织学,血清丸激素水平,氧化应激标志物,氧化 (NO) 途径和与亡相关的基因表达 (Fas,Bax).
主要成果:
- 伊卡林对莱迪格细胞无毒性,细胞毒性降低.
- 高剂量的伊卡里因显著改善了丸系数,精子生成和丸结构.
- 伊卡林治疗降低了甲 (MDA) 和氧化物 (NO) 水平,同时增加了总抗氧化能力 (TAOC) 和超氧化物失调酶 (T-SOD) 活性.
- 伊卡里因抑制了巴克斯和法斯的亲细胞灭亡基因的表达.
结论:
- 伊卡林改善了雄性小鼠的氧化应激诱导的丸损伤.
- 伊卡林通过调节抗氧化能力,氧化信号传递和抑制亡来保护精子生成.
更多相关视频
14:26A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice
Published on: April 7, 2014
15.6K
09:41Functional Assessment of Kinesin-7 CENP-E in Spermatocytes Using In Vivo Inhibition, Immunofluorescence and Flow Cytometry
Published on: December 28, 2021
1.9K
相关概念视频
Mutagenicity and Carcinogenicity
1.4K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.4K
Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
